Antegrade Intestinal Fluid Reinfusion for Prevention of Low Anterior Resection Syndrome After Low Anterior Resection: a Single-Center, Prospective Randomized Controlled Trial.

Abroad (travel likely)RecruitingPHASE2, PHASE3

Conditions

Low Anterior Resection Syndrome · Rectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Contact: Study coordinator (Peirong Ding, M.D) · dingpr@sysucc.org.cn · 86-020-87343920

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

Rectal Cancer · Total Neoadjuvant Treatment · Neoadjuvant Therapy

Abroad (travel likely)RecruitingPHASE2, PHASE3

Vilnius, Lithuania

Improving Functional Outcomes and Quality of Life in Patients With Rectal Cancer After Surgery With Intensified Follow-up & Surveillance

LARS - Low Anterior Resection Syndrome · Rectal Cancer Surgery · Rectal Cancer

Abroad (travel likely)RecruitingPHASE3

Basel, Switzerland · Bern, Switzerland

Comparison of Transanal Irrigation and Glycerol Suppositories in Treatment of Low Anterior Resection Syndrome

Low Anterior Resection Syndrome · Rectal Cancer

Abroad (travel likely)RecruitingPHASE3

Aarhus, Denmark

Personalized Care Pathways for Bowel Symptoms in Rectal Cancer patients_development of E-diary

Rectal Cancer · LARS - Low Anterior Resection Syndrome

Abroad (travel likely)Recruiting

Leuven, Belgium